HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Fatty liver disease in obesity

Non-alcoholic fatty liver disease (NAFLD) is a common liver condition closely linked to obesity. In individuals with obesity, excess fat accumulates in the liver, leading to inflammation and potential scarring. Over time, NAFLD can progress to more severe conditions such as cirrhosis and liver failure. This condition is often associated with metabolic disorders like insulin resistance, high cholesterol, and hypertension. Weight management is critical in treating and preventing NAFLD, as losing even a small percentage of body weight can significantly reduce liver fat and inflammation. A combination of a low-calorie diet, regular exercise, and pharmacological treatments when necessary can help reduce fat accumulation in the liver and prevent further damage, improving liver function and overall health outcomes.

Committee Members
Speaker at World Obesity and Weight Management Congress 2025 - Russell Rising

Russell Rising

D & S Consulting Services Inc, United States
Speaker at World Obesity and Weight Management Congress 2025 - Jeane Silva

Jeane Silva

Augusta University, United States
Speaker at World Obesity and Weight Management Congress 2025 - F Buck Willis

F Buck Willis

Belize Bible College, Punta Gorda, Belize
WOC 2025 Speakers
Speaker at World Obesity and Weight Management Congress 2025 - Charles Bernard

Charles Bernard

Criteria for Success, Inc., United States
Speaker at World Obesity and Weight Management Congress 2025 - Nicolaus Dahlmann

Nicolaus Dahlmann

Institute for Biometry and Nutrition, Germany
Speaker at World Obesity and Weight Management Congress 2025 - Fabiana Sant Anna Evangelista

Fabiana Sant Anna Evangelista

University of Sao Paulo, Brazil
Speaker at World Obesity and Weight Management Congress 2025 - Colleen Lindsey

Colleen Lindsey

Leading Notes, United States
Tags

Submit your abstract Today

Watsapp